Insider Selling Broadens Across Mid-Cap Growth and Medical Device Names
Kestra Medical Technologies sees coordinated disposals from CFO, CCO, CBO and other officers while executives at Cactus, Samsara, AppFolio and Sea Limited trim holdings into strength
A dense cluster of Form 4 filings shows Kestra Medical Technologies officers collectively selling well over $1.9 million in stock, alongside larger single disposals at Cactus ($4.99 million), Samsara ($10.1 million), Curbline Properties ($5.2 million) and AppFolio ($1.6 million). Sea Limited insiders, including a company president, trimmed into a strong quarter.
MARKET REPORTBEARISH